Zur Person
Forschungsfelder und / oder Lehrgebiete
Fachgebiete:
- Analytische Chemie
- Metabolomics
- Zellkultur
- Nanomedizin
- Molekulare Medizin
Publikationen
Kaiser, Lars
2026 | |||
| Lars Kaiser, Oliver Riester, Hans-Peter Deigner | Practical considerations for optimizing untargeted metabolomics with Synapt XS HRMS : A tutorial | Journal of Chromatography A, 1778.2026(July), 2026 | BibTeX | RIS | DOI | URN |
2025 | |||
| Wilhelm E. Krames, Defne I. Dayi, Lars Kaiser, Oliver Riester, Michael Himmelhaus, René Csuk, Hans-Peter Deigner | WGM Sensors for future diagnostics : small molecules to whole organisms | Biosensors and Bioelectronics: X, 26.2025(October), 2025 | BibTeX | RIS | DOI | URN |
2024 | |||
| Teresa Schätzl, Vanessa Todorow, Lars Kaiser, Helga Weinschrott, Benedikt Schoser, Hans-Peter Deigner, Peter Meinke, Matthias Kohl | Meta-analysis towards FSHD reveals misregulation of neuromuscular junction, nuclear envelope, and spliceosome | Communications biology, Vol.7.2024, 2024 | BibTeX | RIS | DOI | URN |
| Simone Rentschler, Sandra Doss, Lars Kaiser, Helga Weinschrott, Matthias Kohl, Hans-Peter Deigner, Martin Sauer | Metabolic Biomarkers of Liver Failure in Cell Models and Patient Sera : Toward Liver Damage Evaluation In Vitro | International Journal of Molecular Sciences, 25.2024(24), 2024 | BibTeX | RIS | DOI | URN |
| Oliver Riester, Lars Kaiser, Stefan Laufer, Hans-Peter Deigner | Rapid Phenotypic Antibiotics Susceptibility Analysis by a 3D Printed Prototype | Advanced Science, 11.2024(21), 2024 | BibTeX | RIS | DOI |
| Isabel Quint, Jonathan Simantzik, Lars Kaiser, Stefan Laufer, René Csuk, David Smith, Matthias Kohl, Hans-Peter Deigner | Ready-to-use nanopore platform for label-free small molecule quantification: Ethanolamine as first example | Nanomedicine: Nanotechnology, Biology and Medicine, 55.2024(January), 2024 | BibTeX | RIS | DOI |
2023 | |||
| Isabel Quint, Jonathan Simantzik, Lars Kaiser, Stefan Laufer, René Csuk, David Smith, Matthias Kohl, Hans-Peter Deigner | Ready-to-use nanopore platform for ethanolamine quantification using an aptamer-based strand displacement assay | bioRXiv: The Preprint Server for Biology, 2023 | BibTeX | RIS | DOI |
2022 | |||
| Max Borgolte, Isabel Quint, Lars Kaiser, René Csuk, Hans-Peter Deigner | A Fluorescence-Based Competitive Antibody Binding Assay for Kynurenine, a Potential Biomarker of Kidney Transplant Failure | Diagnostics, 12.2022(6), 2022 | BibTeX | RIS | DOI |
| Jessica Jung, Lars Kaiser, Hans-Peter Deigner, Magnus S. Schmidt | Continuous synthesis of bromoalkyl glycosides by Fischer glycosylation in a microreactor | Journal of Flow Chemistry, 12.2022(1), pp. 9-15, 2022 | BibTeX | RIS | DOI | URN |
| Lars Kaiser | Identification and characterization of underlying mechanisms of the adverse effects of DEHP on myeloid hematopoiesis | Doctoral thesis, 2022 | BibTeX | RIS | DOI | URN |
| Susanne Jacksch, Christoph König, Dominik Kaiser, Lars Kaiser, Mirko Weide, Sylvia Schnell, Hans-Peter Deigner, Markus Egert | Using OMICS-technologies to unravel the mystery of malodour formation in washing machines and on washed laundry | VAAM Jahrestagung, Annual Conference of the Association for General and Applied Microbiology 2022 digital, 21. - 23. Feburuar 2022, Düsseldorf/Jülich, Germany, 2022 | BibTeX | RIS |
2021 | |||
| Saeb Aliwaini, Bassam Abu Thaher, Ihab Al-Masri, Nabil Shurrab, Said El-Kurdi, Dieter Schollmeyer, Basem Qeshta, Mariam Ghunaim, René Csuk, Stefan Laufer, Lars Kaiser, Hans-Peter Deigner | Design, Synthesis and Biological Evaluation of Novel Pyrazolo[1,2,4]triazolopyrimidine Derivatives as Potential Anticancer Agents | Molecules, 26.2021(13), 2021 | BibTeX | RIS | DOI | URN |
| Markus Blaess, Lars Kaiser, Oliver Sommerfeld, René Csuk, Hans-Peter Deigner | Drug triggered pruritus, rash, papules, and blisters – is AGEP a clash of an altered sphingolipid-metabolism and lysosomotropism of drugs accumulating in the skin? | Lipids in Health and Disease, Vol.20.2021, 2021 | BibTeX | RIS | DOI | URN |
| Markus Blaess, Lars Kaiser, Oliver Sommerfeld, René Csuk, Hans-Peter Deigner | Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19 | International Journal of Molecular Sciences, 22.2021(4 Article 1797), 2021 | BibTeX | RIS | DOI |
| Simone Rentschler, Lars Kaiser, Hans-Peter Deigner | Emerging Options for the Diagnosis of Bacterial Infections and the Characterization of Antimicrobial Resistance | International Journal of Molecular Sciences, 22.2021(1 Article 456), 2021 | BibTeX | RIS | DOI |
| Teresa Schätzl, Lars Kaiser, Hans-Peter Deigner | Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update | Orphanet Journal of Rare Diseases, 16.2021(Artikel 129), 2021 | BibTeX | RIS | DOI | URN |
| Lars Kaiser, Isabel Quint, René Csuk, Manfred Jung, Hans-Peter Deigner | Lineage-Selective Disturbance of Early Human Hematopoietic Progenitor Cell Differentiation by the Commonly Used Plasticizer Di-2-ethylhexyl Phthalate via Reactive Oxygen Species: Fatty Acid Oxidation Makes the Difference | Cells, 10.2021(10), 2021 | BibTeX | RIS | DOI | URN |
| Nico Laur, Lars Kaiser, Hans-Peter Deigner, Ralf Kinscherf | Sequential Analysis of Trace Elements in a Micro Volume Urine Sample Using Inductively Coupled Plasma Mass Spectrometry | Applied Scienes, 11.2021(9 Article 3740), 2021 | BibTeX | RIS | DOI |
2020 | |||
| Markus Blaess, Lars Kaiser, Martin Sauer, René Csuk, Hans-Peter Deigner | COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks | International Journal of Molecular Sciences, 21.2020(14 Article 4953), 2020 | BibTeX | RIS | DOI | URN |
| Christoph Ruppert, Lars Kaiser, Lisa Jacob, Stefan Laufer, Matthias Kohl, Hans-Peter Deigner | Duplex Shiny app quantification of the sepsis biomarkers C-reactive protein and interleukin-6 in a fast quantum dot labeled lateral flow assay | Journal of Nanobiotechnology, 18.2020(Artikel 130), 2020 | BibTeX | RIS | DOI | URN |
| Nico Laur, Ralf Kinscherf, Karolina Pomytkin, Lars Kaiser, Otto Knes, Hans-Peter Deigner | ICP-MS trace element analysis in serum and whole blood | PLOS ONE, 15.2020(5 Article e0233357), 2020 | BibTeX | RIS | DOI | URN |
| Markus Bläss, Lars Kaiser, Martin Sauer, Hans-Peter Deigner | Lysosomotropic Active Compounds — Hidden Protection against COVID-19 / SARS-CoV-2 Infection? | Preprints, 2020 | BibTeX | RIS | DOI |
| Lars Kaiser, Helga Weinschrott, Isabel Quint, Markus Blaess, René Csuk, Manfred Jung, Matthias Kohl, Hans-Peter Deigner | Metabolite Patterns in Human Myeloid Hematopoiesis Result from Lineage-Dependent Active Metabolic Pathways | International Journal of Molecular Sciences, 21.2020(17 Article 6092), 2020 | BibTeX | RIS | DOI | URN |
| Markus Blaess, Lars Kaiser, Oliver Sommerfeld, Simone Rentschler, René Csuk, Hans-Peter Deigner | Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19 | Frontiers in Pharmacology, 11.2020(November Article 584881), 2020 | BibTeX | RIS | DOI | URN |
2018 | |||
| Lars Kaiser, Julia Weisser, Matthias Kohl, Hans-Peter Deigner | Small molecule detection with aptamer based lateral flow assays: Applying aptamer-C-reactive protein cross-recognition for ampicillin detection | Scientific Reports, Vol.8.2018, 2018 | BibTeX | RIS | DOI | URN |
2017 | |||
| Nour-Imene Zahaf, Alexander E. Lang, Lars Kaiser, Christiane D. Fichter, Silke Lassmann, A. McCluskey, Anke Augspach, Klaus Aktories, Gudula Schmidt | Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cells | Scientific Reports, Vol.7.2017, 2017 | BibTeX | RIS | DOI |